ReviewCurrent oncology reports2026

Reprogrammed Lipid Metabolism as a Gatekeeper of Hepatocarcinogenesis: from Enzyme Regulation to Precision Therapy.

Luxi Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.